Stevens Capital Management’s Bio-Techne TECH Stock Holding History

Stevens Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,294	Closed	-$393K	–	303
2023 Q1	$393K	Buy	+5,294	New	+$408K	0.1%	134
2021 Q4	–	Sell	-2,332	Closed	-$283K	–	279
2021 Q3	$283K	Buy	+2,332	New	+$284K	0.12%	136
2019 Q3	–	Sell	-16,236	Closed	-$846K	–	770
2019 Q2	$846K	Buy	+16,236	New	+$818K	0.04%	389
2019 Q1	–	Sell	-11,312	Closed	-$409K	–	885
2018 Q4	$409K	Sell	11,312 -45,184	-80%	-$1.89M	0.02%	529
2018 Q3	$2.88M	Buy	+56,496	New	+$2.5M	0.11%	233
2018 Q2	–	Sell	-33,580	Closed	-$1.27M	–	975
2018 Q1	$1.27M	Buy	33,580 +21,184	+171%	+$749K	0.05%	369
2017 Q4	$401K	Buy	+12,396	New	+$394K	0.02%	592
2017 Q2	–	Sell	-10,216	Closed	-$260K	–	1070
2017 Q1	$260K	Sell	10,216 -37,552	-79%	-$969K	0.01%	724
2016 Q4	$1.23M	Buy	47,768 +9,776	+26%	+$257K	0.05%	399
2016 Q3	$1.04M	Buy	+37,992	New	+$1.04M	0.04%	401
2015 Q1	–	Sell	-57,540	Closed	-$1.33M	–	1233
2014 Q4	$1.33M	Buy	+57,540	New	+$1.32M	0.04%	364
2013 Q4	–	Sell	-50,788	Closed	-$1.02M	–	1223
2013 Q3	$1.02M	Buy	+50,788	New	+$964K	0.03%	480

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Stevens Capital Management's TECH Position: Q2 2023 in Review

Stevens Capital Management sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 5,294 shares — an estimated $393K sold.

Stevens Capital Management first reported a position in TECH in Q3 2013 and held it in 12 quarters. The position peaked at $2.88M in Q3 2018. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

Stevens Capital Management reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
Stevens Capital Management sold 5,294 Bio-Techne shares in Q2 2023, an estimated $393K.
Stevens Capital Management first reported a position in Bio-Techne in Q3 2013 and held it in 12 quarters.
Stevens Capital Management's Bio-Techne position peaked at $2.88M in Q3 2018.
529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Stevens Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.